Target Entity: Satiya Nutraceuticals Private Limited (and its wholly owned subsidiary Juizo Advisory Private Limited)
Type of Deal: Acquisition of minority stake (tranche-based)
Stake/Capacity: 24.09% stake acquired on a fully diluted basis, increasing Marico's aggregate stake from 60% to 84.09%
Deal Value: ₹1,012.03 Crores for the current tranche (24.09% stake)
Aggregate consideration for 84.09% stake: ₹1,392.07 Crores
Remaining 14.09% stake acquisition: Base consideration of up to ₹592 Crores plus additional consideration subject to milestones
Funding Source: Cash consideration
Financial Impact:
Satiya Nutraceuticals' consolidated turnover:
- FY 2025-26: ₹864.31 Crores
- FY 2024-25: ₹432.84 Crores
- FY 2023-24: ₹155.32 Crores
The strategic investment has expanded Marico's total addressable market in value-added foods and nutrition segments as well as presence in rapidly growing personal care and wellness categories.
Timeline:
- Current tranche (24.09% stake) completed on October 5, 2026
- Remaining 14.09% stake acquisition scheduled for July 2027, subject to terms and conditions of definitive agreements
Strategic Rationale:
Expansion into health, wellness and personal care categories through the PLIX brand, which is a leading plant-based nutrition & personal care brand with strong presence in rapidly growing health and wellness segments.
Approval Status:
No governmental or regulatory approvals required. The acquisition involves related party transactions (with Founders of Satiya Nutraceuticals and their relatives/related entities) but are on an arm's length basis. The Promoter/Promoter Group of Marico do not have any interest in the transaction.